.
Exactly one year ago today, on November 21, 2018, The Salgi Esophageal Cancer Research Foundation awarded a grant for esophageal cancer research! This was the second research project funded in less than seven years since the charity was founded in 2011.
The research funding was awarded to Dr. Donald Low at Virginia Mason Medical Center with Dr. George Hanna of St Mary’s Hospital (Imperial College London) as co-investigator. Their research, which is currently underway, intends to establish a non-invasive test for the detection of esophageal cancer that is based upon the unique signature of volatile organic compounds (VOCs) within exhaled breath and to analyze exhaled VOCs in response to therapeutic intervention in patients.
Esophageal cancer is considered one of the fastest growing and deadliest cancers in the United States and western world. Esophageal cancer has increased over 700% in the past three decades and has an overall 5 year survival rate of only 19.2%. There are no routine or standard screenings to improve early detection of esophageal cancer and symptoms often arise late, once the cancer is considered advanced or “distant” (spread to lymph nodes and other organs.) Stage IV esophageal cancer has a survival rate of only 4.8%. Despite all of these facts, csophageal cancer research critically underfunded
Donate today to help change these statistics and fund more worthy projects! SALGI.org/donate
Dr. Donald Low, Virginia Mason
.
.
.
.
The Salgi Esophageal Cancer Research Foundation 